Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Cipla and Wellthy Therapeutics announce Partnership

Posted On: 2019-02-19 11:56:08

Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") and Wellthy Therapeutics Private Limited ("Wellthy Therapeutics") today announced that they have entered into a partnership to offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of diabetology and cardiology.

Under the agreement, a multi-lingual clinically-validated digital disease management platform will be made available to patients living with diabetes or cardiovascular diseases via doctors' clinics or co-packaging on select Cipla brands. The platform brings together behavioural science, real world clinical evidence and artificial intelligence to provide real time monitoring, coaching and advice to patients, and virtual clinical assistance to doctors.

This partnership is a result of Cipla's campaign, lnnoventia, which was envisioned as a first-of-its-kind challenge by an Indian pharmaceutical company to encourage innovation-led entrepreneurship and to harness disruptive ideas in healthcare to fulfil unmet patient needs.

Umang Vohra, MD & Global CEO of Cipla, said, "The future of healthcare will be driven by increased use of technology, and this partnership gives Cipla the ability to offer this combination of ·prescription drugs and artificial intelligence-powered digital therapeutics to patients in cardio-metabolic health. It will allow patients to make informed decisions and take charge of their own health. By pairing our pharmacotherapy strengths with the digital approach to healthcare taken by Wellthy Therapeutics, Cipla will add to its diversified portfolio in the cardio-metabolic area to provide holistic care to patients from awareness, diagnosis and compliance to wellbeing."

Abhishek Shah, Co-founder & CEO of Wellthy Therapeutics, said, "We are excited to work with Cipla to bring digital therapeutics to patients in India. Companion digital therapeutics are redefining the treatment of chronic conditions, by helping personalise and simplify disease management for patients, and driving precision clinical insights to clinicians. With the combination of Cipla's world class formulations and clinically validated digital therapeutics of Wellthy Therapeutics, we look forward to helping empower and inspire millions of patients to achieve better, sustainable health outcomes."

Cardiovascular Diseases (CVDs) are the leading cause of mortality in India today. cutting across the urban-rural divide. Diabetes and hypertension are significant risk factors leading to CVDs. Over 72 million1 Indians are estimated to be diabetic while approximately 10% of the population is estimated to be pre-diabetic2, and 29% of the population is estimated to be hypertensive3.

Shares of CIPLA LTD. was last trading in BSE at Rs.541.35 as compared to the previous close of Rs. 540.4. The total number of shares traded during the day was 53786 in over 787 trades.

The stock hit an intraday high of Rs. 544.3 and intraday low of 532.5. The net turnover during the day was Rs. 29005499.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Punjab & Sind Bank declares Financial Results for the Quarter/ Year Ended 31.03.2019

Excel Industries Ltd Board approves Dividend of Rs. 18.75

NGL Fine-Chem Ltd board recommends final dividend of Rs. 1.75

NCC Ltd Board recommends Dividend of Rs. 1.50 for FY19

Dixon Technologies India Ltd Board recommends Final Dividend of Rs. 2

Housing and Urban Development Corporation Ltd Board approves Dividend for 2018-19

PNC Infratech Ltd Board approves Dividend of Rs. 0.50

Zuari Global Ltd Board recommends Dividend of Rs. 1 for 2018-19

BATA India Ltd Board recommends Dividend of Rs. 6.25 for FY19

Whirlpool of India Ltd Board recommends Dividend for FY 2018-19

Grasim Industries Ltd Board recommends Dividend of Rs. 7

Meghmani Organics Ltd Board recommends Final Dividend of Rs. 0.40 for FY19

Ashok Leyland Ltd Board recommends Dividend of Rs. 3.10

Pudumjee Paper Products Ltd Board approves Dividend of Rs. 0.15 for 2018-19

H G Infra Engineering Ltd Board approves Dividend of Rs. 0.50

Page Industries Ltd Board approves Dividend of Rs. 41

Ponni Sugars Erode Ltd board recommends Dividend of Rs. 2 for 2018-19

Kaira Can Co Ltd Board recommends Dividend of Rs. 6.50

Sudarshan Chemical Industries Ltd Board recommends Dividend of Rs. 6

Varroc Engineering Ltd announces Q4 & FY19 results

Zenith Fibres Ltd Board recommends Dividend for 2018-19

Varroc Engineering Ltd board recommends dividend of Rs. 4 for 2018-19

Ashoka Buildcon Limited Consolidated Revenue crossed Rs 5,000 Crores in FY19

Lancer Container Lines Ltd declares Q4, FY19 results

CG-VAK Software & Exports Ltd Board approves Dividend for FY 2018-19

DIL LTD Board recommends Final Dividend of Rs. 1.25

Welspun India Ltd Bord recommends Dividend of Rs. 0.30

HeidelbergCement India Ltd Board approves Dividend of Rs. 3

Vardhman Holdings Ltd board recommends dividend of Rs. 5 for FY19

Emmbi Industries Ltd Board recommends Dividend for 2018-19

Unichem Laboratories Ltd Board recommends Dividend of Rs. 4 for FY2018-19

Panama Petrochem Ltd Board recommends Dividend of Rs. 1.20 for FY19

Kaycee Industries Ltd Board recommends Dividend of Rs. 10 for 2018-19

Salzer Electronics Ltd board recommends dividend of Rs. 1.60 for 2018-19

AMJ Land Holdings Ltd Board approves Dividend of Rs. 0.30 for 2018-19

Empire Industries Ltd board recommends dividend of Rs. 25 for 2018-19

Advanced Enzyme Technologies Ltd announces Financial Results for the quarter and year ended March 2019

Kridhan Infra Ltd arm files for insolvency in Singapore

Infosys Completes Formation of Strategic Partnership with ABN AMRO in the Netherlands

Genesys International Corporation Ltd Board approves Dividend for 2018-19

I G Petrochemicals Ltd reports Q4, FY19 results

ITD Cementation India Ltd board recommends dividend of Rs. 0.40

Prima Plastics Ltd board approves dividend of Rs. 1 for FY19

Acrysil Ltd Board approves Dividend of Rs. 1.20

Munjal Auto Industries Ltd Board approves Dividend of Rs. 1

Ramco Systems FY19 revenue grows 16% and Net Profit by 45% in INR

IG Petrochemicals Ltd Board approves Dividend for FY19

Balaji Telefilms Ltd Board recommends Final Dividend for 2018-19

Sagar Cements Ltd Board recommends Dividend of Rs. 2.50

Asian Star Company Ltd board recommends dividend of Rs. 1.5







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019